Antiplatelet therapy in acute coronary syndromes: implications for nursing practice

Kathy Berra1, Barbara J Fletcher, Eileen Handberg

  • 1Stanford Prevention Research Center, Stanford University School of Medicine, USA. kberra@stanford.edu

Insights

Acute coronary syndromes (ACSs) require advanced care beyond rest. Antiplatelet therapies are crucial for managing ACS, improving outcomes for myocardial infarction (MI) patients.

Area of Science:

  • Cardiology
  • Pharmacology
  • Nursing

Background:

  • Myocardial infarction (MI) care has advanced significantly, evolving from basic rest to complex interventions.
  • The terminology has shifted from MI to acute coronary syndromes (ACSs), encompassing unstable angina, non-ST-elevation MI, and ST-elevation MI.
  • ACS refers to clinical symptoms arising from acute myocardial ischemia.

Purpose of the Study:

  • To review the pathophysiology of ACS.
  • To elucidate the critical role of antiplatelet therapies in managing ACS.
  • To discuss the impact of antiplatelet therapies on platelet function and the evolving role of nursing in patient care.

Main Methods:

  • Literature review focusing on ACS pathophysiology.
  • Analysis of antiplatelet therapy mechanisms and effects.
  • Examination of nursing management strategies for ACS patients on antiplatelet agents.

Main Results:

  • Antiplatelet therapies are vital in managing ACS by inhibiting platelet aggregation and activation.
  • These therapies address both short- and long-term risks associated with atherosclerosis and ischemia.
  • Nursing management has adapted to incorporate the complexities of antiplatelet therapies in ACS care.

Conclusions:

  • Antiplatelet therapies are indispensable in the contemporary management of acute coronary syndromes.
  • Understanding the pathophysiology and therapeutic mechanisms is key for effective patient care.
  • Nurses play a pivotal role in managing patients with ACS receiving antiplatelet treatments.

Related Concept Videos

Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...